A CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development. The G-7 Finance Ministers endorsed the approach and five donors (Canada, Italy, Norway, UK and Russia, and the Gates Foundation) committed $1.5 billion to create an incentive for a vaccine against the strains of pneumococcus disease prevalent in low-income countries. For updates, see Advance Market Commitments for Vaccines, a joint effort of the GAVI Alliance and the World Bank.
***
 Making a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development (R&D) by public and charitable bodies, accelerating the development of vital new vaccines for the developing world.
This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
This generation can leave an historic legacy. By creating arrangements that devote the same scientific effort to diseases of the poor as we put into diseases of the rich, we can make a lasting contribution to the defeat of poverty.
Newest
Popular
Experts
Publications
Events
Multimedia
Selected Works
-
To mark the start of the new year, my guest is Amanda Glassman, CGD’s new director of global health. I asked Amanda, who previously worked at the Inter-American Development Bank, the Brookings Institution, and USAID, where she sees opportunities for progress on global health in 2011 and...
-
In this two-minute 2006 video clip, Ruth Levine, then CGD senior fellow and director for global health, tells the story of CGD’s Making Markets for Vaccines initiative. She describes how a CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development....
-
Would an Advance Market Commitment work in climate finance? CGD visting senior associate Jan von der Goltz joined a panel on Advance Market Commitments (AMCs) at the Marketplace on Innovative Financial Solutions for Development in Paris, March 4, 2010. (For a round-up of the best ideas from the...
-
Donors are considering committing in advance to purchase vaccines against diseases concentrated in low-income countries to spur research and development on vaccines for neglected diseases. How much money is needed? The authors of this paper find that a commitment comparable in size to the average...
-
New medicines are usually financed by a mixture of public funding by governments, philanthropic giving, and investment by private firms. Private investment is especially important in paying for and managing the later stages of clinical trials, regulatory approval, and investment in manufacturing...
-
Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
-
On Thursday April 7, 2005 - World Health Day - CGD launched a report with the potential to save millions of lives. Making Markets for Vaccines: Ideas to Action presents an achievable approach to creating incentives for pharmaceutical and biotechnology manufacturers in the rich world to invest in...
-
Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
-
Donors are considering committing in advance to purchase vaccines against diseases concentrated in low-income countries to spur research and development on vaccines for neglected diseases. How much money is needed? The authors of this paper find that a commitment comparable in size to the average...
-
New medicines are usually financed by a mixture of public funding by governments, philanthropic giving, and investment by private firms. Private investment is especially important in paying for and managing the later stages of clinical trials, regulatory approval, and investment in manufacturing...
-
In this two-minute 2006 video clip, Ruth Levine, then CGD senior fellow and director for global health, tells the story of CGD’s Making Markets for Vaccines initiative. She describes how a CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development....
-
To mark the start of the new year, my guest is Amanda Glassman, CGD’s new director of global health. I asked Amanda, who previously worked at the Inter-American Development Bank, the Brookings Institution, and USAID, where she sees opportunities for progress on global health in 2011 and...
-
Would an Advance Market Commitment work in climate finance? CGD visting senior associate Jan von der Goltz joined a panel on Advance Market Commitments (AMCs) at the Marketplace on Innovative Financial Solutions for Development in Paris, March 4, 2010. (For a round-up of the best ideas from the...
-
On Thursday April 7, 2005 - World Health Day - CGD launched a report with the potential to save millions of lives. Making Markets for Vaccines: Ideas to Action presents an achievable approach to creating incentives for pharmaceutical and biotechnology manufacturers in the rich world to invest in...
-
-
Making Markets for Vaccines - Ideas to Action (Brief)
- Apr 7, 2005
New medicines are usually financed by a mixture of public funding by governments, philanthropic giving, and investment by private firms. Private investment is especially important in paying for and managing the later stages of clinical trials, regulatory approval, and investment in manufacturing...
-
Making Markets for Vaccines: Ideas to Action
- Apr 7, 2005
Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
-
Making Markets for Vaccines: from ideas to action
- Apr 7, 2005
On Thursday April 7, 2005 - World Health Day - CGD launched a report with the potential to save millions of lives. Making Markets for Vaccines: Ideas to Action presents an achievable approach to creating incentives for pharmaceutical and biotechnology manufacturers in the rich world to invest in...
There are no selected works related to this topic.
|
|
Print
Share
